Concepedia

Publication | Closed Access

Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

363

Citations

20

References

2012

Year

Abstract

clinicaltrials.gov Identifier: NCT00810147

References

YearCitations

Page 1